menu
    • menu

    Company profile for LumiThera

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company...
    At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company’s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LumiTheraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    19578 10th Ave NE STE 200 Poulsbo, Washington 98370
    Telephone
    Telephone
    +44-2076601516
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lumithera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lumithera-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alcon to buy LumiThera's light-Based therapy for dry AMD
    Alcon to buy LumiThera's light-Based therapy for dry AMD

    09 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/alcon-buy-lumitheras-light-based-therapy-dry-amd

    FIERCE BIOTECH
    09 Jul 2025
    Share Share
    Alcon Acquires LumiThera for Early AMD Treatment Device
    Alcon Acquires LumiThera for Early AMD Treatment Device

    07 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250702399355/en/Alcon-to-Acquire-LumiThera-and-Its-Photobiomodulation-Device-for-the-Treatment-of-Early-and-Intermediate-Dry-Age-Related-Macular-Degeneration-AMD

    BUSINESSWIRE
    07 Jul 2025
    Share Share
    LumiThera LIGHTSITE IIIB Trial Shows Extended Vision Improvement
    LumiThera LIGHTSITE IIIB Trial Shows Extended Vision Improvement

    08 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250508837574/en/LumiTheras-LIGHTSITE-IIIB-Extension-Trial-Topline-Results-Show-Extended-Vision-Improvement-in-Dry-AMD-Subjects

    BUSINESSWIRE
    08 May 2025
    Share Share
    FDA clears 1st treatment for dry AMD, with LumiThera’s Valeda
    FDA clears 1st treatment for dry AMD, with LumiThera’s Valeda

    07 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/fda-clears-first-treatment-dry-amd-lumitheras-light-based-valeda-system

    FIERCE BIOTECH
    07 Nov 2024
    Share Share
    LumiThera Acquires Diopsys to create light-based theranostic approach
    LumiThera Acquires Diopsys to create light-based theranostic approach

    10 Nov 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/lumithera-inc-announces-creation-of-a-light-based-theranostic-approach-to-treat-ocular-disease-with-acquisition-of-diopsys-inc-/?s=79

    BIOSPACE
    10 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search